First Time Loading...

Revolution Medicines Inc
NASDAQ:RVMD

Watchlist Manager
Revolution Medicines Inc Logo
Revolution Medicines Inc
NASDAQ:RVMD
Watchlist
Price: 35.54 USD -1.47% Market Closed
Updated: Apr 16, 2024

Intrinsic Value

RVMD's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. [ Read More ]

The intrinsic value of one RVMD stock under the Base Case scenario is 1.06 USD. Compared to the current market price of 35.54 USD, Revolution Medicines Inc is Overvalued by 97%.

Key Points:
RVMD Intrinsic Value
Base Case
1.06 USD
Overvaluation 97%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Revolution Medicines Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling RVMD stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Revolution Medicines Inc

Provide an overview of the primary business activities
of Revolution Medicines Inc.

What unique competitive advantages
does Revolution Medicines Inc hold over its rivals?

What risks and challenges
does Revolution Medicines Inc face in the near future?

Has there been any significant insider trading activity
in Revolution Medicines Inc recently?

Summarize the latest earnings call
of Revolution Medicines Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Revolution Medicines Inc.

Provide P/S
for Revolution Medicines Inc.

Provide P/E
for Revolution Medicines Inc.

Provide P/OCF
for Revolution Medicines Inc.

Provide P/FCFE
for Revolution Medicines Inc.

Provide P/B
for Revolution Medicines Inc.

Provide EV/S
for Revolution Medicines Inc.

Provide EV/GP
for Revolution Medicines Inc.

Provide EV/EBITDA
for Revolution Medicines Inc.

Provide EV/EBIT
for Revolution Medicines Inc.

Provide EV/OCF
for Revolution Medicines Inc.

Provide EV/FCFF
for Revolution Medicines Inc.

Provide EV/IC
for Revolution Medicines Inc.

Show me price targets
for Revolution Medicines Inc made by professional analysts.

What are the Revenue projections
for Revolution Medicines Inc?

How accurate were the past Revenue estimates
for Revolution Medicines Inc?

What are the Net Income projections
for Revolution Medicines Inc?

How accurate were the past Net Income estimates
for Revolution Medicines Inc?

What are the EPS projections
for Revolution Medicines Inc?

How accurate were the past EPS estimates
for Revolution Medicines Inc?

What are the EBIT projections
for Revolution Medicines Inc?

How accurate were the past EBIT estimates
for Revolution Medicines Inc?

Compare the revenue forecasts
for Revolution Medicines Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Revolution Medicines Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Revolution Medicines Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Revolution Medicines Inc compared to its peers.

Compare the P/E ratios
of Revolution Medicines Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Revolution Medicines Inc with its peers.

Analyze the financial leverage
of Revolution Medicines Inc compared to its main competitors.

Show all profitability ratios
for Revolution Medicines Inc.

Provide ROE
for Revolution Medicines Inc.

Provide ROA
for Revolution Medicines Inc.

Provide ROIC
for Revolution Medicines Inc.

Provide ROCE
for Revolution Medicines Inc.

Provide Gross Margin
for Revolution Medicines Inc.

Provide Operating Margin
for Revolution Medicines Inc.

Provide Net Margin
for Revolution Medicines Inc.

Provide FCF Margin
for Revolution Medicines Inc.

Show all solvency ratios
for Revolution Medicines Inc.

Provide D/E Ratio
for Revolution Medicines Inc.

Provide D/A Ratio
for Revolution Medicines Inc.

Provide Interest Coverage Ratio
for Revolution Medicines Inc.

Provide Altman Z-Score Ratio
for Revolution Medicines Inc.

Provide Quick Ratio
for Revolution Medicines Inc.

Provide Current Ratio
for Revolution Medicines Inc.

Provide Cash Ratio
for Revolution Medicines Inc.

What is the historical Revenue growth
over the last 5 years for Revolution Medicines Inc?

What is the historical Net Income growth
over the last 5 years for Revolution Medicines Inc?

What is the current Free Cash Flow
of Revolution Medicines Inc?

AI Assistant can make mistakes. Consider checking important information.
Financials

Balance Sheet Decomposition
Revolution Medicines Inc

Current Assets 1.9B
Cash & Short-Term Investments 1.9B
Receivables 1.3m
Other Current Assets 25.1m
Non-Current Assets 182.4m
PP&E 100m
Intangibles 72.3m
Other Non-Current Assets 10.1m
Current Liabilities 143.9m
Accounts Payable 61.8m
Accrued Liabilities 78.2m
Other Current Liabilities 3.9m
Non-Current Liabilities 91.7m
Other Non-Current Liabilities 91.7m
Efficiency

Earnings Waterfall
Revolution Medicines Inc

Revenue
11.6m USD
Operating Expenses
-498.8m USD
Operating Income
-487.2m USD
Other Expenses
50.8m USD
Net Income
-436.4m USD

Free Cash Flow Analysis
Revolution Medicines Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

RVMD Profitability Score
Profitability Due Diligence

Revolution Medicines Inc's profitability score is 11/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Declining ROE
Negative 1-Year Revenue Growth
Declining ROIC
11/100
Profitability
Score

Revolution Medicines Inc's profitability score is 11/100. The higher the profitability score, the more profitable the company is.

RVMD Solvency Score
Solvency Due Diligence

Revolution Medicines Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Revolution Medicines Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RVMD Price Targets Summary
Revolution Medicines Inc

Wall Street analysts forecast RVMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RVMD is 39.61 USD with a low forecast of 34.34 USD and a high forecast of 46.2 USD.

Lowest
Price Target
34.34 USD
3% Downside
Average
Price Target
39.61 USD
11% Upside
Highest
Price Target
46.2 USD
30% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

RVMD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

RVMD Price
Revolution Medicines Inc

1M 1M
+15%
6M 6M
+4%
1Y 1Y
+45%
3Y 3Y
-12%
5Y 5Y
+23%
10Y 10Y
+23%
Annual Price Range
35.54
52w Low
18.35
52w High
37.41
Price Metrics
Average Annual Return -4.02%
Standard Deviation of Annual Returns 31.95%
Max Drawdown -73%
Shares Statistics
Market Capitalization 5.9B USD
Shares Outstanding 164 690 000
Percentage of Shares Shorted 7.56%

RVMD Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Revolution Medicines Inc Logo
Revolution Medicines Inc

Country

United States of America

Industry

Biotechnology

Market Cap

5.9B USD

Dividend Yield

0%

Description

Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. The company is headquartered in Redwood City, California and currently employs 188 full-time employees. The company went IPO on 2020-02-13. The firm is focused on developing targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways, with particular emphasis on the renin angiotensin system (RAS) and mammalian target of rapamycin (mTOR) signaling pathways. The company’s research and development (R&D) pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. Its RAS(ON) Inhibitors in development include RMC-6236, RMC-6291, RMC-9805 and RMC-8839, and a pipeline of research compounds targeting additional RAS variants. The RAS Companion Inhibitors in clinical development include RMC-4630 (SHP2) and RMC-5552 (mTORC1/4EBP1). The Company’s tri-complex technology enables to discover small molecule inhibitors of targets lacking intrinsic drug binding sites by inducing new druggable pockets.

Contact

CALIFORNIA
Redwood City
700 Saginaw Dr
+14157663638.0
https://www.revmed.com/

IPO

2020-02-13

Employees

188

Officers

CEO, President & Chairman
Dr. Mark A. Goldsmith Ph.D.
Chief Financial Officer
Mr. Jack Anders
Chief Operating Officer
Ms. Margaret A. Horn J.D.
President of Research & Development
Dr. Stephen M. Kelsey FRC Path., FRCP, M.D.
Executive Vice President of Clinical Development
Ms. Xiaolin Wang
Co-Founder & Chairman of Scientific Advisory Board
Dr. Martin D. Burke M.D., Ph.D.
Show More
Academic Co-Founder & Member of Scientific Advisory Board
Dr. Kevan M. Shokat Ph.D.
Chief Information Officer
Mr. Walter Reiher Ph.D.
Chief Scientific Officer
Ms. Jan Smith Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one RVMD stock?

The intrinsic value of one RVMD stock under the Base Case scenario is 1.06 USD.

Is RVMD stock undervalued or overvalued?

Compared to the current market price of 35.54 USD, Revolution Medicines Inc is Overvalued by 97%.